Non-comparative, Open-label, Multiple Cohort, Phase 1/2 Study to Evaluate Nivolumab in Patients With Virus-associated Tumors (CheckMate 358): Efficacy and Safety in Merkel Cell Carcinoma - Topalian, S L BS; Hollebecque, A; Awada, A (Cancer Res, 2017)
[Abstract CT074]